Streetbeat News

Regulatory

GRAM

MSOS

Gold Flora CEO Laurie Holcomb discusses the potential positive impact of regulatory changes on smaller cannabis businesses, which have struggled to make money under current conditions.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:26 pm

MSOS

VRNOF

Verano President Darren Weiss expresses optimism about the momentum in cannabis law liberalization, highlighting public support and potential Congressional movement. He notes the challenges US companies face compared to Canadian counterparts and the significance of rescheduling.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:24 pm

GRAM

MSOS

Gold Flora's CEO Laurie Holcomb highlights issues in California's cannabis market, including illicit market disparity, tax structures, and the need for more retail stores. The company plans to raise funds to address these challenges.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:21 pm

MSOS

YOLO

AdvisorShares VP of Marketing, Mackenzie Peterson, discusses the benefits of removing 280E, suggesting that companies can use the additional cash to further their business. This could positively impact cannabis-focused ETFs like MSOS and YOLO.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:18 pm

AMD

GNRC

NVDA

TLT

TSLA

UVE

The article discusses the impact of rising yields and a higher neutral rate on various financial assets, including the iShares 20+ Year Treasury Bond ETF (TLT), NVIDIA Corp (NVDA), Advanced Micro Devices (AMD), Tesla Inc (TSLA), and several insurance and generator companies due to Hurricane Milton. It highlights the potential for significant stock moves, the importance of the 10-year Treasury yield, and the implications of the Fed's neutral rate. The article also mentions the positive money flows in major tech stocks and ETFs, and the impact of geopolitical tensions on market volatility.

Portfolio Pulse from The Arora Report

October 08, 2024 | 3:17 pm

HIMS

LLY

The FDA has removed Eli Lilly's weight loss drug, tirzepatide, from the shortage list, sparking controversy. Critics argue this decision disregards ongoing supply issues and favors special interests. Hims & Hers Health may still see strong demand for compounded drugs.

Portfolio Pulse from Vandana Singh

October 08, 2024 | 3:16 pm

GRAM

MSOS

Gold Flora's CEO, Laurie Holcomb, discusses the company's vertical integration strategy, which allows for flexibility in operations and financial management. The focus is on improving free cash flow and simplifying tax structures, particularly in relation to 280E tax regulations.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:14 pm

META

Russia's communications regulator has banned the instant messaging platform Discord, as reported by Reuters citing TASS.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 3:11 pm